Clinical Trials Sponsored by Fox Chase Cancer Center

Total 8165 results

Fox Chase Cancer Center

Not yet recruiting

Pacritinib w/ Talazoparib in Pts w/ Myeloproliferative Neoplasms Unresponsive to JAK2 Inhibition

Primary Myelofibrosis | Polycythemia Vera | Chronic Myelomonocytic Leukemia | Essential Thrombocytosis | Post-polycythemia Vera Myelofibrosis | Post-essential Thrombocythemia Myelofibrosis

United States
Fox Chase Cancer Center

Recruiting

Enfortumab Vedotin Schedule De-escalation in Metastatic Urothelial Carcinoma

Urothelial Carcinoma | Metastatic Urothelial Carcinoma | Locally Advanced Urothelial Carcinoma

United States
Fox Chase Cancer Center

Recruiting

Iron Replacement to Reduce Anemia During Neoadjuvant Chemotherapy (Iron-RANC)

Anemia

United States
Fox Chase Cancer Center

Recruiting

5-aminolevulinic Acid In Advanced Malignancies

Advanced Solid Tumor

United States
Fox Chase Cancer Center

Recruiting

Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma

Renal Cell Carcinoma | Bladder Cancer | Urothelial Carcinoma | Ureter Cancer | Urethral Cancer

United States
Fox Chase Cancer Center

Recruiting

Pulsed Low Dose Rate Radiation With Concurrent Chemotherapy for Non-Small Cell Lung Cancer and Esophageal Cancer

Esophageal Cancer | Lung Cancer

United States
Fox Chase Cancer Center

Terminated

Trial Using Octreotide to Enhance Liver Recovery After Hepatectomy

Major Liver Resection

United States
Fox Chase Cancer Center

Suspended

Pulse-low-dose Rate (PLDR) Radiation in Pancreatic Cancer

Pancreatic Cancer

United States
Fox Chase Cancer Center

Completed

Women's Health Communication Study

Gynecologic Cancer

United States
Fox Chase Cancer Center

Active, not recruiting

Palliative and Oncology Care Intervention: Symptom COACH

Cancer of Head and Neck

United States
Fox Chase Cancer Center

Terminated

Chemoembolization Using Irinotecan in Treating Patients With Liver Metastases From Metastatic Colon or Rectal Cancer

Mucinous Adenocarcinoma of the Rectum | Signet Ring Adenocarcinoma of the Rectum | Liver Metastases | Mucinous Adenocarcinoma of the Colon | Signet Ring Adenocarcinoma of the Colon | Stage IV Colon Cancer | Stage IV Rectal Cancer | Recurrent Colon Cancer | Recurrent Rectal Cancer

United States
Fox Chase Cancer Center

Completed

A Biobehavioral Model of Diabetes Risk in Chinese Immigrants

Diabetes Mellitus, Type 2

United States
Fox Chase Cancer Center

Withdrawn

Brigatinib in Relapsed or Refractory ALK-Positive Anaplastic Large Cell Lymphoma

Anaplastic Large Cell Lymphoma, ALK-Positive

United States
Fox Chase Cancer Center

Completed

Pilot Study to Investigate The Diagnostic Yield and Utility of 22g and 19g Endobronchial Ultrasound Transbronchial Needle Aspirate

Non Small Cell Lung Cancer

United States
Fox Chase Cancer Center

Terminated

VM110 in Detection of Microscopic Tumors: A Phase I Study

Pancreatic Cancer | Ovarian Cancer

United States
Fox Chase Cancer Center

Completed

Dose Dense MVAC for Muscle Invasive Bladder Cancer

Muscle Invasive Bladder Cancer | High Risk Urothelial Carcinoma of the Upper Urinary Tracts

United States
Fox Chase Cancer Center

Terminated

Gemcitabine Hydrochloride and Cisplatin Before Surgery in Treating Patients With Muscle Invasive Bladder Cancer

Stage III Bladder Cancer | Distal Urethral Cancer | Proximal Urethral Cancer | Squamous Cell Carcinoma of the Bladder | Urethral Cancer Associated With Invasive Bladder Cancer | Stage II Bladder Cancer

United States
Fox Chase Cancer Center

Withdrawn

A Study of Pembrolizumab in Combination With Epacadostat in Women With Recurrent/Metastatic Endometrial Carcinoma

Recurrent/ Metastatic Endometrial Carcinoma

United States
Fox Chase Cancer Center

Terminated

Nilotinib in Advanced Gastrointestinal Stromal Tumors (GIST) (07060)

Gastrointestinal Stromal Tumors

United States
Fox Chase Cancer Center

Recruiting

Buprenorphine for Cancer Pain

Cancer-Related Pain

United States
Fox Chase Cancer Center

Recruiting

Dose Attenuated Chemotherapy in Compromised Patients With Lung Cancer

Lung Cancer | Non Small Cell Lung Cancer | Small-cell Lung Cancer

United States
Fox Chase Cancer Center

Recruiting

Redefining FOLFIORINOX in Older Pancreatic Cancer Patients

Metastatic Pancreatic Cancer

United States
Fox Chase Cancer Center

Recruiting

Atorvastatin ± Aspirin in Lynch Syndrome Syndrome

Lynch Syndrome

United States
Fox Chase Cancer Center

Suspended

HM-178: Assessing Methods for Improvement in Methotrexate Toxicity Management and Detection of Central Nervous System Involvement of Aggressive Lymphoma

Lymphoma

United States
Fox Chase Cancer Center

Active, not recruiting

Perioperative Risk Study (PRS)

Surgery | Tumors | Primary Neoplasm | Secondary Neoplasm

United States
Fox Chase Cancer Center

Completed

PET-CT in Determining the Radioembolization Dose Delivered to Patients With Liver Metastasis, Primary Liver Cancer, or Biliary Cancer

Unspecified Adult Solid Tumor, Protocol Specific | Advanced Adult Primary Liver Cancer | Recurrent Adult Primary Liver Cancer | Recurrent Extrahepatic Bile Duct Cancer | Adult Primary Hepatocellular Carcinoma | Metastatic Extrahepatic Bile Duct Cancer | Stage D Adult Primary Liver Cancer (BCLC)

United States
Fox Chase Cancer Center

Active, not recruiting

Risk Enabled Therapy After Initiating Neoadjuvant Chemotherapy for Bladder Cancer (RETAIN)

Urothelial Carcinoma of the Bladder

United States
Fox Chase Cancer Center

Withdrawn

A Pilot Study of Circulating Tumor DNA Adaptive Risk Maintenance Approach for Bladder Cancer (CARMA) (CARMA)

Metastatic Urothelial Carcinoma
Fox Chase Cancer Center

Withdrawn

Sotorasib in KRAS G12C Mutated, Resectable, Stage Ib-IIIA NSCLC

Non-Small Cell Lung Cancer

United States
Fox Chase Cancer Center

Active, not recruiting

Molecular Monitoring With Circulating Tumor DNA and Nivolumab Maintenance

Diffuse Large B Cell Lymphoma

United States
Fox Chase Cancer Center

Active, not recruiting

Study to Assess TOPO2A as a Biomarker for Sensitivity to Doxorubicin/Doxil in Soft Tissue Sarcoma

Soft Tissue Sarcoma

United States
Fox Chase Cancer Center

Withdrawn

Everolimus, Erlotinib Hydrochloride, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer Previously Treated With Radiation Therapy

Tongue Cancer | Recurrent Metastatic Squamous Neck Cancer With Occult Primary | Recurrent Salivary Gland Cancer | Recurrent Squamous Cell Carcinoma of the Hypopharynx | Recurrent Squamous Cell Carcinoma of the Larynx | Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity | Recurrent Squamous... and other conditions

United States
Fox Chase Cancer Center

Completed

Bicalutamide With or Without Metformin for Biochemical Recurrence in Overweight or Obese Prostate Cancer Patients (BIMET-1)

Cancer of Prostate

United States
Fox Chase Cancer Center

Terminated

Regorafenib Plus 5-Fluorouracil/Leucovorin Beyond Progression in mCRC

Colorectal Cancer

United States
Fox Chase Cancer Center

Terminated

Combination of Cetuximab, Capecitabine, and Oxaliplatin With or Without Bevacizumab

Colorectal Neoplasms

United States
Fox Chase Cancer Center

Completed

Observation Study of Patients With Non-Small Cell Lung Cancer and Esophageal Cancer Treated With Chemo-Radiation Followed by Surgery

Esophageal Cancer | Lung Cancer

United States
Fox Chase Cancer Center

Completed

A Dose-Escalation Study of Onc201 Administered Every One or Three Weeks in Advanced Solid Tumors and Multiple Myeloma

Multiple Myeloma | Advanced Solid Tumors

United States
Fox Chase Cancer Center

Terminated

Quinacrine-Capecitabine Combinatorial Therapy for Advanced Stage Colorectal Adenocarcinoma

Colorectal Adenocarcinoma

United States
Fox Chase Cancer Center

Terminated

Investigation of Contralateral Arytenoid Sparing IMRT for T1a & T2a Larynx Cancer & Analysis of Post-treatment Laryngeal Function

Laryngeal Neoplasms

United States
Fox Chase Cancer Center

Completed

Intensity-Modulated Radiation Therapy With or Without Decreased Radiation Dose to Erectile Tissue in Treating Patients With Stage II Prostate Cancer

Sexual Dysfunction | Prostate Cancer | Sexuality and Reproductive Issues

United States
Fox Chase Cancer Center

Completed

Feasibility Bowel Dysfunction Program After Low Anterior Resection

Rectal Cancer | Low Anterior Resection

United States
Fox Chase Cancer Center

Terminated

Depletion of Myeloid Derived Suppressor Cells to Enhance Anti PD-1 Therapy

Non Small Cell Lung Cancer Stage IIIB

United States
Fox Chase Cancer Center

Terminated

Development of Real-time Image-guided Radiotherapy

Breast Cancer | Lung Cancer | Skin Cancer

United States
Fox Chase Cancer Center

Terminated

Impact of Ribociclib on Head and Neck Squamous Cell Cancer

Squamous Cell Carcinoma of the Head and Neck

United States
Fox Chase Cancer Center

Completed

Adherence to Survivorship Care Guidelines in Health Care Providers for Non-Small Cell Lung Cancer and Colorectal Cancer Survivor Care

Mucinous Adenocarcinoma of the Rectum | Signet Ring Adenocarcinoma of the Rectum | Stage IIA Rectal Cancer | Stage IIB Rectal Cancer | Stage IIC Rectal Cancer | Stage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Stage IIIA Non-small Cell Lung Cancer | Stage IIIB Non-small... and other conditions

United States
Fox Chase Cancer Center

Completed

Genetic Epidemiology Risk Assessment Program or Usual Care in Colorectal Cancer Screening for Healthy Participants

Colorectal Cancer | Healthy, no Evidence of Disease

United States
Fox Chase Cancer Center

Withdrawn

Paclitaxel, Topotecan, and Estramustine in Treating Patients With Metastatic Hormone-Refractory Prostate Cancer

Prostate Cancer
Fox Chase Cancer Center

Completed

Study of Paclitaxel, Carboplatin, and Cetuximab for Advanced Lung Cancer

Carcinoma, Non-Small-Cell Lung

United States
Fox Chase Cancer Center

Recruiting

Adaptive Radiation for Abdominopelvic Metastases

Malignant Neoplasm of Stomach | Neoplasm - Soft Tissue Pelvis Malignant Secondary

United States
Fox Chase Cancer Center

Recruiting

Post-Discharge Risk-Based Management in Patients Undergoing High-Risk Elective Major Cancer Operations (PRS II)

Cancer | Surgery

United States

Clinical Trials Sponsored by Fox Chase Cancer Center

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Croatia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations